Related Experiment Videos
Heart and bone tumors in transgenic mice
R R Behringer1, J J Peschon, A Messing
1Laboratory of Reproductive Physiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.
Summary
Transgenic mice expressing simian virus 40 (SV40) T-antigen in round spermatids unexpectedly developed cardiac and bone tumors. Testicular cells were resistant to neoplastic transformation by this oncogene.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Tissue-specific cancer development can be induced in mice using simian virus 40 (SV40) large tumor (T) antigen.
- Investigating oncogene susceptibility in specific cell types is crucial for understanding cancer mechanisms.
Purpose of the Study:
- To assess the neoplastic transformation potential of SV40 T-antigen in haploid round spermatids.
- To generate and characterize transgenic mouse models for studying tissue-specific oncogenesis.
Main Methods:
- Generation of transgenic mice harboring a chimeric gene (SV40 T-antigen linked to mouse protamine 1 gene regulatory sequences).
- Analysis of transgene expression patterns in various tissues, including testes, heart, and temporal bone.
- Histopathological examination and immunostaining for T-antigen in tumor tissues and testes.
Main Results:
- The transgene was expressed in round spermatids, heart, and temporal bone.
- Unexpectedly, cardiac rhabdomyosarcomas (right atrium) and bilateral temporal bone osteosarcomas developed.
- No testicular pathology was observed, and T-antigen was not detected in testicular tissue.
- SV40 transcripts showed differential processing in testis versus tumor tissues.
Conclusions:
- Round spermatids are surprisingly resistant to neoplastic transformation by SV40 T-antigen, despite transgene expression.
- Transgenic mice develop specific tumors in the heart and temporal bone, offering models for cardiac and bone neoplasia research.
- Established transgenic lines provide a valuable resource for studying cardiac and bone physiology and cancer development.